Tivity Health Inc (TVTY) Given Average Rating of “Buy” by Analysts

Tivity Health Inc (NASDAQ:TVTY) has been given an average recommendation of “Buy” by the eight brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, five have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $47.40.

Several analysts recently weighed in on the company. BidaskClub lowered Tivity Health from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 16th. SunTrust Banks reaffirmed a “buy” rating and issued a $46.00 price objective on shares of Tivity Health in a research note on Friday, August 3rd. Finally, Zacks Investment Research lowered Tivity Health from a “hold” rating to a “sell” rating in a research note on Thursday, October 18th.

Several hedge funds have recently made changes to their positions in TVTY. Van Berkom & Associates Inc. boosted its stake in shares of Tivity Health by 284.3% during the second quarter. Van Berkom & Associates Inc. now owns 1,773,856 shares of the company’s stock valued at $62,440,000 after purchasing an additional 1,312,287 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Tivity Health by 157.2% during the second quarter. Wells Fargo & Company MN now owns 1,150,544 shares of the company’s stock valued at $40,499,000 after purchasing an additional 703,206 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Tivity Health by 12.3% during the second quarter. BlackRock Inc. now owns 5,238,626 shares of the company’s stock valued at $184,399,000 after purchasing an additional 572,771 shares in the last quarter. Eagle Asset Management Inc. boosted its stake in shares of Tivity Health by 15.3% during the second quarter. Eagle Asset Management Inc. now owns 1,757,955 shares of the company’s stock valued at $61,880,000 after purchasing an additional 233,057 shares in the last quarter. Finally, Carillon Tower Advisers Inc. boosted its stake in shares of Tivity Health by 28.9% during the second quarter. Carillon Tower Advisers Inc. now owns 992,903 shares of the company’s stock valued at $34,950,000 after purchasing an additional 222,724 shares in the last quarter.

NASDAQ:TVTY traded up $0.17 during trading hours on Friday, hitting $34.97. The company’s stock had a trading volume of 1,969 shares, compared to its average volume of 376,535. The firm has a market capitalization of $1.36 billion, a PE ratio of 20.98, a price-to-earnings-growth ratio of 1.44 and a beta of 0.59. Tivity Health has a twelve month low of $29.95 and a twelve month high of $48.50.

Tivity Health (NASDAQ:TVTY) last released its quarterly earnings data on Thursday, August 2nd. The company reported $0.53 earnings per share for the quarter, meeting the consensus estimate of $0.53. The business had revenue of $151.90 million for the quarter, compared to analyst estimates of $152.98 million. Tivity Health had a return on equity of 28.38% and a net margin of 13.79%. Tivity Health’s revenue was up 9.4% compared to the same quarter last year. During the same period last year, the firm posted $0.41 earnings per share. As a group, sell-side analysts anticipate that Tivity Health will post 2.15 EPS for the current fiscal year.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Article: Understanding Market Liquidity

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply